KMTS - Company ID 0001877184
KESTRA MEDICAL TECHNOLOGIES, LTD. trades as KMTS and has a market capitalization of $1.55 B, making it the #2339 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $59.81M, up 115.1% from the prior year and net income of -$113.81M. This page tracks KESTRA MEDICAL TECHNOLOGIES, LTD. through 105 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-18 |
| Insider sale notice | 144 | 2026-05-15 |
| Insider trade | 4 | 2026-04-16 |
| Insider sale notice | 144 | 2026-04-15 |
| SCHEDULE 13G/A | - | 2026-04-08 |
| S-3ASR | - | 2026-04-01 |
| Insider trade | 4 | 2026-03-30 |
| Insider trade | 4 | 2026-03-19 |
The largest companies sharing KESTRA MEDICAL TECHNOLOGIES, LTD.'s SEC industry classification (surgical & medical instruments & apparatus).
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) has a market capitalization of $1.55 B as of 2026-07-09, ranking #2339 among US-listed companies.
KESTRA MEDICAL TECHNOLOGIES, LTD. reported revenue of $59.81M for fiscal year 2025, an increase of 115.1% year over year.
In its latest fiscal year KESTRA MEDICAL TECHNOLOGIES, LTD. reported a net loss of $113.81M.